Tumor-stroma relationships: Who’s the driver?

 Cell Cycle News & Views to:

AK Witkiewicz, D Whitaker-Menezes, A Dasgupta, NJ Philp, Z Lin, R Gandara, S Sneddon, UE Martinez-Outschoorn, F Sotgia, MP Lisanti. Using the 'reverse Warburg effect' to identify high-risk breast cancer patients: Stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle 2012; 11: 1108- 17.
PMID: 22313602 DOI: 10.4161/cc.11.6.19530

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1753 - 1753
doi
10.4161/cc.20185
Type
Cell Cycle News & Views
 Metrics
 Cite This Article
 Permissions
Creative Commons License Permissions
 Reprints
Tumor-stroma relationships: Who’s the driver?